CDC withdraws support for PCR tests
Dec 13, 2021|3:07 PM
Lab alert withdraws standing request to FDA to grant emergency use authorization for PCR tests to detect SARS-CoV-2
The Centers for Disease Control and Prevention (CDC) will no longer recognize
PCR tests as valid methods of diagnosing COVID-19 by the end of this year. The CDC announced in a
lab alert on its website that it will be withdrawing its standing request to the Food and Drug Administration (FDA) to grant emergency use authorization for PCR tests to be used to detect SARS-CoV-2. The request, which was issued in February 2020, will be withdrawn on December 31, 2021, a move which signals that the CDC no longer approves of the use of PCR tests as valid diagnostic methods for COVID-19.
In the CDC’s own words:
“After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only.”